| While CEOs often catch the multimillion-dollar paychecks, it’s diligent workers that form a company, and some of them get paid handsomely as well. We ranked the top 10 most generous biopharma companies by median employee pay in 2018. Most are R&D-focused biotechs, with a small number of products and lower headcounts compared to your typical multibillion-dollar Big Pharma—but even the highest median salary among the large multinationals couldn’t compete with No. 10 on our list. Meanwhile, we charted some of the successes and failures of our past Fierce 15 awardees, in the lead up to 2019’s soon-to-be-announced class of winners. | |
|
Featured Story | | | Tuesday, September 17, 2019 While biopharma CEOs often catch the limelight for their multimillion-dollar paychecks, it is every diligent worker that forms a company—and some of them also get paid handsomely. Here, we rank the top 10 most generous biopharma companies by median employee pay in 2018. |
|
|---|
|
| This week's sponsor is Optum. | |  | |
Top Stories Of The Week Monday, September 16, 2019 This year marks the 17th time we’ve sought out the best private biotech companies, and as we look forward to officially becoming an adult next year, we thought it high time to see how our alumni are getting on. Wednesday, September 18, 2019 An online pharmacy has again stuck it to the FDA in a citizen petition after tipping off regulators to the existence of a potentially cancer-causing impurity in Zantac and other heartburn medicines. Friday, September 13, 2019 Amgen Thursday posted what appeared to be a fairly innocuous update about its drug Kyprolis and other pipeline assets, but a deeper read turned up a nasty surprise. Tuesday, September 17, 2019 Novo Nordisk’s Ozempic is off to a blazing start, and the company just threw more fuel on the fire with a pair of trial wins. Ozempic topped both SGLT2 drug Invokana from J&J and Novo’s own GLP-1 drug Victoza in head-to-head phase 3 contests. Friday, September 13, 2019 One of the last major, late-stage attempt at stopping Alzheimer’s using a BACE inhibitor has ended up on the trash pile with so many others. Monday, September 16, 2019 The recent recall of Takeda's Natpara for hypoparathyroidism illustrates one of the paradoxes of modern drug development. Orphan drugs can be a salvation for patients, but there are big consequences if supply is interrupted. Monday, September 16, 2019 Lundbeck has struck a deal to buy Alder BioPharmaceuticals for almost $2 billion. The takeover centers on a near-approval anti-CGRP antibody that could address Lundbeck’s need for revenue drivers to mitigate the loss of patent protection on Northera. Wednesday, September 18, 2019 Merck & Co.’s Keytruda has racked up yet another first-of-its-kind approval, this time in a combo with partner Eisai’s Lenvima. Drug regulators have granted green lights to the pair for women with certain advanced endometrial carcinoma. Monday, September 16, 2019 Medtronic and Novo Nordisk have agreed to integrate their digital offerings for people with diabetes, including the sharing of data between continuous glucose monitoring devices and smart insulin pens. Wednesday, September 18, 2019 Sanofi is among the largest drugmakers in Bangladesh, but the company has told local officials it plans to exit, according to reports. The company employed more than 1,200 there as of 2016, divided between a manufacturing plant and corporate office. Monday, September 16, 2019 Terazosin, a decades-old drug to treat enlarged prostate, could provide a new way to address Parkinson’s disease by targeting PGK1, scientists at Capital Medical University in Beijing and the University of Iowa found. | This week's sponsor is FiercePharmaMarketing. | |  | |
Resources Sponsored by: Reprints Desk, Inc. Slashing your R&D costs is easier than you think. Sponsored by: Roche and IQVIA A global landscape study of funding trends and innovations. Sponsored by: BioAnalytix Download the White Paper and learn how detailed characterization can guide successful development of gene therapy products. Sponsored by: Blue Matter, strategic consultants in the life sciences White paper providing an overview of precision medicine in oncology, as well as a look ahead at future developments and keys to success for pharmaceutical and diagnostics companies. Sponsored by: Patheon, by Thermo Fisher Scientific Avoid potential risks to the patient as well as costly interruptions during development. Sponsored by: Vineti Developing a cell therapy, gene therapy, or personalized cancer vaccine? Modern data management makes a critical difference in operational and regulatory outcomes. This whitepaper will help your team leverage the latest data strategies for success. Sponsored by: AlphaSense AI-powered research tools are making it easier to source confident healthcare market intelligence with accuracy and efficiency -- download now to learn more about improving your competitive research strategy. Sponsored by: Elemental Machines Your lab is talking to you, are you listening? Sponsored by: Frenova Want to be sure your renal research protocol design is fit for the real world? Sponsored by: Recro Gainesville Vetting CDMOs but unsure what to look for in prospective partners’ multiproduct facilities? Sponsored by: Baxter BioPharma Solutions Check out Baxter BioPharma Solutions’ whitepaper to learn considerations and options for developing a product in a prefilled syringe. Sponsored by: Kinaxis Download this life sciences industry spotlight to discover how concurrent planning can help you overcome complex supply chain challenges to drive down costs and improve efficiency. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. | 
